Board of Directors
Matthew Rizzo is a Partner, Credit Opportunities at OrbiMed Advisors, L.L.C. Mr. Rizzo is focused on healthcare royalty and structured finance investments. Previously, Mr. Rizzo was at Ikaria as a Senior Director in business development for pharmaceutical licensing and acquisitions. Prior to Ikaria, Mr. Rizzo was a Vice President at Fortress Investment Group, focused on healthcare investments in the Drawbridge Special Opportunities Funds. Prior to Fortress, he was at GlaxoSmithKline where he worked in business and commercial analysis. Mr. Rizzo received his M.B.A. from Duke University and his B.S. from the State University of New York at Buffalo.
Matthew Henderson joined OmniGuide in 2018 as the Vice President of Global Sales. Mr. Henderson brings nearly 25 years of medical device experience, repeatedly demonstrating year-over-year revenue growth across a variety of organizations and surgical specialties with a patient focused approach. Prior to joining OmniGuide, Mr. Henderson served as President and General Manager of 3 Shape, Inc., achieving triple digit growth in capital revenue and procedural usage. Mr. Henderson’s broad experience includes Johnson and Johnson’s Ethicon Division, holding strategic roles in sales leadership, global marketing, finance, national accounts, and Acting Vice President of Sales and Marketing of the disruptive Reconstructive Pelvic Surgery & Urology division, launched 9 new surgical procedures including PMA.
Mr. Henderson holds a B.S. in Marketing from the Pennsylvania State University and an MBA from the University of Delaware.
Michael Eggenberg is a Managing Director focused on healthcare royalty and structured finance investments. Previously, Mr. Eggenberg was a Managing Director at Fortress Investment Group, focused on Special Opportunities Funds. Prior to Fortress, Mr. Eggenberg held positions at CIT, Wells Fargo and Nations Bank. Mr. Eggenberg received his B.S. in Finance and General Business from Drexel University.